L-Cycloserine

Generic Name
L-Cycloserine
Brand Names
Seromycin
Drug Type
Small Molecule
Chemical Formula
C3H6N2O2
CAS Number
339-72-0
Unique Ingredient Identifier
AK7DRB7FMO
Background

Antibiotic substance produced by Streptomyces garyphalus.

Indication

本品与其他抗结核药联合，用于经一线药物（如吡嗪酰胺、链霉素、异烟肼、利福平和乙胺丁醇）治疗失败的患者。本品还可用于治疗非结核分枝杆菌感染如鸟复合分枝杆菌病的治疗。

Associated Conditions
Pulmonary Tuberculosis (TB), Tuberculosis, Extrapulmonary, Grade 1, grade 2, grade 3, grade 4 Urinary Tract Infection
Associated Therapies
-
Clinical Trials
Related News

Augmentation of Cognitive Training in Children With TBI With D-Cyloserine

First Posted Date
2014-12-09
Last Posted Date
2014-12-09
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
30
Registration Number
NCT02312635
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine

First Posted Date
2014-12-02
Last Posted Date
2017-09-19
Lead Sponsor
Mclean Hospital
Target Recruit Count
2
Registration Number
NCT02304432

NMDA Receptors in Motor Learning in Humans

First Posted Date
2014-03-10
Last Posted Date
2018-11-07
Lead Sponsor
Emory University
Target Recruit Count
14
Registration Number
NCT02082912
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder

First Posted Date
2014-02-20
Last Posted Date
2020-06-09
Lead Sponsor
University of Texas at Austin
Target Recruit Count
152
Registration Number
NCT02066792
Locations
🇺🇸

Boston University, Boston, Massachusetts, United States

🇺🇸

University of Texas at Austin, Austin, Texas, United States

🇺🇸

Rush University Medical Center, Chicago, Illinois, United States

Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception

First Posted Date
2013-11-15
Last Posted Date
2018-10-12
Lead Sponsor
University of Oxford
Target Recruit Count
90
Registration Number
NCT01985750
Locations
🇬🇧

Oxford Centre for Clinical Magnetic Resonance Imaging, Oxford, Oxfordshire, United Kingdom

D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions

First Posted Date
2013-11-13
Last Posted Date
2020-03-25
Lead Sponsor
NYU Langone Health
Target Recruit Count
58
Registration Number
NCT01981759
Locations
🇺🇸

Sheppard Pratt, Baltimore, Maryland, United States

🇺🇸

New York Langone Medical Center/Bellevue Hospital, New York, New York, United States

Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine

First Posted Date
2013-09-17
Last Posted Date
2021-05-19
Lead Sponsor
University of Texas at Austin
Target Recruit Count
53
Registration Number
NCT01944423
Locations
🇺🇸

University of Texas at Austin, Austin, Texas, United States

Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia

Phase 2
Completed
Conditions
Agoraphobia
Interventions
Behavioral: CBT
Drug: D-Cycloserine
First Posted Date
2013-08-27
Last Posted Date
2014-05-19
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
73
Registration Number
NCT01928823
Locations
🇩🇪

Department of Psychiatry and Psychotherapy, Charité Campus Mitte - Universitätsmedizin Berlin, Berlin, Germany

Effects of Nicotine Replacement Therapy and D-cycloserine on Nicotine Treatment Seekers

First Posted Date
2013-07-25
Last Posted Date
2020-10-08
Lead Sponsor
New York State Psychiatric Institute
Registration Number
NCT01907594
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

NMDA Antagonists in Bipolar Depression

First Posted Date
2013-04-17
Last Posted Date
2016-06-01
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
8
Registration Number
NCT01833897
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy